Review



rabbit anti-human col1 antibody  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Thermo Fisher rabbit anti-human col1 antibody
    IL-1β priming allows successful fracture repair. Upon IL-1β treatment, a trend towards a decrease in chondromodulin was detected, while IL-1β upregulated VEGF and MMP13 ( A ). Safranin-O staining prior to implantation further revealed the increase in chondrocyte lacunae size, suggesting progressive maturation towards chondrocyte hypertrophy ( B ). Following orthotopic implantation, the cartilaginous organoids underwent progressive mineralization with bone bridging being detected in the µCT images after 4 weeks ( C ). µCT quantification revealed a significant increase ( p = 0.0095) in the volume of mineralized tissue in the defect area between BBT3 and BBT3 + IL-1β conditions after 8 weeks ( D ). Histological analysis using safranin-O further revealed accelerated bone formation with cartilage resorption being detected at week 4 ( E ). While bone union was detected after 8 weeks, some cartilaginous remnants could be detected, which indicates progressive cartilage resorption. Immunostaining of human <t>collagen</t> <t>type</t> <t>I</t> further revealed that the newly formed bone was host derived, while some hypertrophic chondrocytes expressed low levels of collagen type I ( F ). Mathematical modelling was used to confirm the cumulative effects of BMP, Wnt, TH and IL-1β in chondrocyte hypertrophy. An increase in hypertrophy chance, along with a decrease in variability, was detected following in vitro stimulation with aforementioned factors. DC: β-catenin Destruction Complex ( G ). The presented data have been collected from experiments ( n = 6) using CY2 cell line. Statistical significance is represented as follow: * p < 0.05; ** p < 0.01; *** p < 0.001, and **** p < 0.0001. The following abbreviations have been used to highlight the tissue composition in the sections: B: bone, C: cartilage, M: bone marrow, T: cartilage-bone turnover site (dotted rectangle) and CR: cartilage remnants
    Rabbit Anti Human Col1 Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti-human col1 antibody/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    rabbit anti-human col1 antibody - by Bioz Stars, 2026-02
    90/100 stars

    Images

    1) Product Images from "Human pluripotent stem cell-derived cartilaginous organoids promote scaffold-free healing of critical size long bone defects"

    Article Title: Human pluripotent stem cell-derived cartilaginous organoids promote scaffold-free healing of critical size long bone defects

    Journal: Stem Cell Research & Therapy

    doi: 10.1186/s13287-021-02580-7

    IL-1β priming allows successful fracture repair. Upon IL-1β treatment, a trend towards a decrease in chondromodulin was detected, while IL-1β upregulated VEGF and MMP13 ( A ). Safranin-O staining prior to implantation further revealed the increase in chondrocyte lacunae size, suggesting progressive maturation towards chondrocyte hypertrophy ( B ). Following orthotopic implantation, the cartilaginous organoids underwent progressive mineralization with bone bridging being detected in the µCT images after 4 weeks ( C ). µCT quantification revealed a significant increase ( p = 0.0095) in the volume of mineralized tissue in the defect area between BBT3 and BBT3 + IL-1β conditions after 8 weeks ( D ). Histological analysis using safranin-O further revealed accelerated bone formation with cartilage resorption being detected at week 4 ( E ). While bone union was detected after 8 weeks, some cartilaginous remnants could be detected, which indicates progressive cartilage resorption. Immunostaining of human collagen type I further revealed that the newly formed bone was host derived, while some hypertrophic chondrocytes expressed low levels of collagen type I ( F ). Mathematical modelling was used to confirm the cumulative effects of BMP, Wnt, TH and IL-1β in chondrocyte hypertrophy. An increase in hypertrophy chance, along with a decrease in variability, was detected following in vitro stimulation with aforementioned factors. DC: β-catenin Destruction Complex ( G ). The presented data have been collected from experiments ( n = 6) using CY2 cell line. Statistical significance is represented as follow: * p < 0.05; ** p < 0.01; *** p < 0.001, and **** p < 0.0001. The following abbreviations have been used to highlight the tissue composition in the sections: B: bone, C: cartilage, M: bone marrow, T: cartilage-bone turnover site (dotted rectangle) and CR: cartilage remnants
    Figure Legend Snippet: IL-1β priming allows successful fracture repair. Upon IL-1β treatment, a trend towards a decrease in chondromodulin was detected, while IL-1β upregulated VEGF and MMP13 ( A ). Safranin-O staining prior to implantation further revealed the increase in chondrocyte lacunae size, suggesting progressive maturation towards chondrocyte hypertrophy ( B ). Following orthotopic implantation, the cartilaginous organoids underwent progressive mineralization with bone bridging being detected in the µCT images after 4 weeks ( C ). µCT quantification revealed a significant increase ( p = 0.0095) in the volume of mineralized tissue in the defect area between BBT3 and BBT3 + IL-1β conditions after 8 weeks ( D ). Histological analysis using safranin-O further revealed accelerated bone formation with cartilage resorption being detected at week 4 ( E ). While bone union was detected after 8 weeks, some cartilaginous remnants could be detected, which indicates progressive cartilage resorption. Immunostaining of human collagen type I further revealed that the newly formed bone was host derived, while some hypertrophic chondrocytes expressed low levels of collagen type I ( F ). Mathematical modelling was used to confirm the cumulative effects of BMP, Wnt, TH and IL-1β in chondrocyte hypertrophy. An increase in hypertrophy chance, along with a decrease in variability, was detected following in vitro stimulation with aforementioned factors. DC: β-catenin Destruction Complex ( G ). The presented data have been collected from experiments ( n = 6) using CY2 cell line. Statistical significance is represented as follow: * p < 0.05; ** p < 0.01; *** p < 0.001, and **** p < 0.0001. The following abbreviations have been used to highlight the tissue composition in the sections: B: bone, C: cartilage, M: bone marrow, T: cartilage-bone turnover site (dotted rectangle) and CR: cartilage remnants

    Techniques Used: Staining, Immunostaining, Derivative Assay, In Vitro



    Similar Products

    97
    Novus Biologicals rabbit anti human col1 antibody
    Rabbit Anti Human Col1 Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti human col1 antibody/product/Novus Biologicals
    Average 97 stars, based on 1 article reviews
    rabbit anti human col1 antibody - by Bioz Stars, 2026-02
    97/100 stars
      Buy from Supplier

    90
    Rockland Immunochemicals anti-human rabbit antibody against col1, 4, or 6
    Anti Human Rabbit Antibody Against Col1, 4, Or 6, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-human rabbit antibody against col1, 4, or 6/product/Rockland Immunochemicals
    Average 90 stars, based on 1 article reviews
    anti-human rabbit antibody against col1, 4, or 6 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Rockland Immunochemicals anti-human rabbit antibody against col1, col4, col6
    Anti Human Rabbit Antibody Against Col1, Col4, Col6, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-human rabbit antibody against col1, col4, col6/product/Rockland Immunochemicals
    Average 90 stars, based on 1 article reviews
    anti-human rabbit antibody against col1, col4, col6 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher rabbit anti-human col1 antibody
    IL-1β priming allows successful fracture repair. Upon IL-1β treatment, a trend towards a decrease in chondromodulin was detected, while IL-1β upregulated VEGF and MMP13 ( A ). Safranin-O staining prior to implantation further revealed the increase in chondrocyte lacunae size, suggesting progressive maturation towards chondrocyte hypertrophy ( B ). Following orthotopic implantation, the cartilaginous organoids underwent progressive mineralization with bone bridging being detected in the µCT images after 4 weeks ( C ). µCT quantification revealed a significant increase ( p = 0.0095) in the volume of mineralized tissue in the defect area between BBT3 and BBT3 + IL-1β conditions after 8 weeks ( D ). Histological analysis using safranin-O further revealed accelerated bone formation with cartilage resorption being detected at week 4 ( E ). While bone union was detected after 8 weeks, some cartilaginous remnants could be detected, which indicates progressive cartilage resorption. Immunostaining of human <t>collagen</t> <t>type</t> <t>I</t> further revealed that the newly formed bone was host derived, while some hypertrophic chondrocytes expressed low levels of collagen type I ( F ). Mathematical modelling was used to confirm the cumulative effects of BMP, Wnt, TH and IL-1β in chondrocyte hypertrophy. An increase in hypertrophy chance, along with a decrease in variability, was detected following in vitro stimulation with aforementioned factors. DC: β-catenin Destruction Complex ( G ). The presented data have been collected from experiments ( n = 6) using CY2 cell line. Statistical significance is represented as follow: * p < 0.05; ** p < 0.01; *** p < 0.001, and **** p < 0.0001. The following abbreviations have been used to highlight the tissue composition in the sections: B: bone, C: cartilage, M: bone marrow, T: cartilage-bone turnover site (dotted rectangle) and CR: cartilage remnants
    Rabbit Anti Human Col1 Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti-human col1 antibody/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    rabbit anti-human col1 antibody - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher antibody rabbit anti-human col1
    IL-1β priming allows successful fracture repair. Upon IL-1β treatment, a trend towards a decrease in chondromodulin was detected, while IL-1β upregulated VEGF and MMP13 ( A ). Safranin-O staining prior to implantation further revealed the increase in chondrocyte lacunae size, suggesting progressive maturation towards chondrocyte hypertrophy ( B ). Following orthotopic implantation, the cartilaginous organoids underwent progressive mineralization with bone bridging being detected in the µCT images after 4 weeks ( C ). µCT quantification revealed a significant increase ( p = 0.0095) in the volume of mineralized tissue in the defect area between BBT3 and BBT3 + IL-1β conditions after 8 weeks ( D ). Histological analysis using safranin-O further revealed accelerated bone formation with cartilage resorption being detected at week 4 ( E ). While bone union was detected after 8 weeks, some cartilaginous remnants could be detected, which indicates progressive cartilage resorption. Immunostaining of human <t>collagen</t> <t>type</t> <t>I</t> further revealed that the newly formed bone was host derived, while some hypertrophic chondrocytes expressed low levels of collagen type I ( F ). Mathematical modelling was used to confirm the cumulative effects of BMP, Wnt, TH and IL-1β in chondrocyte hypertrophy. An increase in hypertrophy chance, along with a decrease in variability, was detected following in vitro stimulation with aforementioned factors. DC: β-catenin Destruction Complex ( G ). The presented data have been collected from experiments ( n = 6) using CY2 cell line. Statistical significance is represented as follow: * p < 0.05; ** p < 0.01; *** p < 0.001, and **** p < 0.0001. The following abbreviations have been used to highlight the tissue composition in the sections: B: bone, C: cartilage, M: bone marrow, T: cartilage-bone turnover site (dotted rectangle) and CR: cartilage remnants
    Antibody Rabbit Anti Human Col1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibody rabbit anti-human col1/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    antibody rabbit anti-human col1 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    93
    Novus Biologicals rabbit anti human col1
    Figure 1 Comparison of the frequency of CD34 + <t>COL1</t> + ( a ) and CD34 + COL1A1 mRNA + fibrocytes ( b ) in the peripheral blood of healthy controls and asthmatic patients. The percentage of cells coexpressing CD34 and COL1 or CD34 and COL1A1 mRNA was calculated on cytospins of total peripheral blood leukocytes. The horizontal lines indicate the medians. * * * P < 0.001 vs. healthy controls by the Mann – Whitney test.
    Rabbit Anti Human Col1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti human col1/product/Novus Biologicals
    Average 93 stars, based on 1 article reviews
    rabbit anti human col1 - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    90
    Rockland Immunochemicals rabbit anti-human col1 1 antibody
    Figure 1 Comparison of the frequency of CD34 + <t>COL1</t> + ( a ) and CD34 + COL1A1 mRNA + fibrocytes ( b ) in the peripheral blood of healthy controls and asthmatic patients. The percentage of cells coexpressing CD34 and COL1 or CD34 and COL1A1 mRNA was calculated on cytospins of total peripheral blood leukocytes. The horizontal lines indicate the medians. * * * P < 0.001 vs. healthy controls by the Mann – Whitney test.
    Rabbit Anti Human Col1 1 Antibody, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti-human col1 1 antibody/product/Rockland Immunochemicals
    Average 90 stars, based on 1 article reviews
    rabbit anti-human col1 1 antibody - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    Image Search Results


    IL-1β priming allows successful fracture repair. Upon IL-1β treatment, a trend towards a decrease in chondromodulin was detected, while IL-1β upregulated VEGF and MMP13 ( A ). Safranin-O staining prior to implantation further revealed the increase in chondrocyte lacunae size, suggesting progressive maturation towards chondrocyte hypertrophy ( B ). Following orthotopic implantation, the cartilaginous organoids underwent progressive mineralization with bone bridging being detected in the µCT images after 4 weeks ( C ). µCT quantification revealed a significant increase ( p = 0.0095) in the volume of mineralized tissue in the defect area between BBT3 and BBT3 + IL-1β conditions after 8 weeks ( D ). Histological analysis using safranin-O further revealed accelerated bone formation with cartilage resorption being detected at week 4 ( E ). While bone union was detected after 8 weeks, some cartilaginous remnants could be detected, which indicates progressive cartilage resorption. Immunostaining of human collagen type I further revealed that the newly formed bone was host derived, while some hypertrophic chondrocytes expressed low levels of collagen type I ( F ). Mathematical modelling was used to confirm the cumulative effects of BMP, Wnt, TH and IL-1β in chondrocyte hypertrophy. An increase in hypertrophy chance, along with a decrease in variability, was detected following in vitro stimulation with aforementioned factors. DC: β-catenin Destruction Complex ( G ). The presented data have been collected from experiments ( n = 6) using CY2 cell line. Statistical significance is represented as follow: * p < 0.05; ** p < 0.01; *** p < 0.001, and **** p < 0.0001. The following abbreviations have been used to highlight the tissue composition in the sections: B: bone, C: cartilage, M: bone marrow, T: cartilage-bone turnover site (dotted rectangle) and CR: cartilage remnants

    Journal: Stem Cell Research & Therapy

    Article Title: Human pluripotent stem cell-derived cartilaginous organoids promote scaffold-free healing of critical size long bone defects

    doi: 10.1186/s13287-021-02580-7

    Figure Lengend Snippet: IL-1β priming allows successful fracture repair. Upon IL-1β treatment, a trend towards a decrease in chondromodulin was detected, while IL-1β upregulated VEGF and MMP13 ( A ). Safranin-O staining prior to implantation further revealed the increase in chondrocyte lacunae size, suggesting progressive maturation towards chondrocyte hypertrophy ( B ). Following orthotopic implantation, the cartilaginous organoids underwent progressive mineralization with bone bridging being detected in the µCT images after 4 weeks ( C ). µCT quantification revealed a significant increase ( p = 0.0095) in the volume of mineralized tissue in the defect area between BBT3 and BBT3 + IL-1β conditions after 8 weeks ( D ). Histological analysis using safranin-O further revealed accelerated bone formation with cartilage resorption being detected at week 4 ( E ). While bone union was detected after 8 weeks, some cartilaginous remnants could be detected, which indicates progressive cartilage resorption. Immunostaining of human collagen type I further revealed that the newly formed bone was host derived, while some hypertrophic chondrocytes expressed low levels of collagen type I ( F ). Mathematical modelling was used to confirm the cumulative effects of BMP, Wnt, TH and IL-1β in chondrocyte hypertrophy. An increase in hypertrophy chance, along with a decrease in variability, was detected following in vitro stimulation with aforementioned factors. DC: β-catenin Destruction Complex ( G ). The presented data have been collected from experiments ( n = 6) using CY2 cell line. Statistical significance is represented as follow: * p < 0.05; ** p < 0.01; *** p < 0.001, and **** p < 0.0001. The following abbreviations have been used to highlight the tissue composition in the sections: B: bone, C: cartilage, M: bone marrow, T: cartilage-bone turnover site (dotted rectangle) and CR: cartilage remnants

    Article Snippet: Sections were then washed with PBS + 1% Tween 20 and blocked with 5% bovine serum albumin (BSA) for 30 min (Sigma, UK), before being incubated with a rabbit anti-human Col1 antibody (1:200, Thermo Scientific, USA) at 4 °C overnight.

    Techniques: Staining, Immunostaining, Derivative Assay, In Vitro

    Figure 1 Comparison of the frequency of CD34 + COL1 + ( a ) and CD34 + COL1A1 mRNA + fibrocytes ( b ) in the peripheral blood of healthy controls and asthmatic patients. The percentage of cells coexpressing CD34 and COL1 or CD34 and COL1A1 mRNA was calculated on cytospins of total peripheral blood leukocytes. The horizontal lines indicate the medians. * * * P < 0.001 vs. healthy controls by the Mann – Whitney test.

    Journal: Mucosal immunology

    Article Title: Interleukin (IL)-4, IL-13, and IL-17A differentially affect the profibrotic and proinflammatory functions of fibrocytes from asthmatic patients.

    doi: 10.1038/mi.2011.60

    Figure Lengend Snippet: Figure 1 Comparison of the frequency of CD34 + COL1 + ( a ) and CD34 + COL1A1 mRNA + fibrocytes ( b ) in the peripheral blood of healthy controls and asthmatic patients. The percentage of cells coexpressing CD34 and COL1 or CD34 and COL1A1 mRNA was calculated on cytospins of total peripheral blood leukocytes. The horizontal lines indicate the medians. * * * P < 0.001 vs. healthy controls by the Mann – Whitney test.

    Article Snippet: For intracellular staining of COL1, cells were permeabilized with 0.3 % saponin solution (Sigma-Aldrich, St Louis, MO) in Tris-buffered saline and sequentially 148 VOLUME 5 NUMBER 2 | MARCH 2012 | www.nature.com/mi incubated with a rabbit anti-human COL1 ( 2 chain) (Novus Biologicals, Littletone, CO), a biotinylated goat anti-rabbit secondary antibody (Novus Biologicals), and rhodamine red X-conjugated streptavidin (Jackson ImmunoResearch, Bar Harbor, ME).

    Techniques: Comparison, MANN-WHITNEY

    Figure 2 Isolation and phenotypic analysis of circulating fibrocytes. CD34 + cells were isolated from the peripheral blood by positive immunomagnetic selection and cultured for 5 days to obtain a pure population of mature fibrocytes. The non-adherent cells were removed after the first 48 h and the adherent cells were reincubated for the next 3 days in fresh medium. Flow cytometric analysis of the isolated cells was performed soon after the immunomagnetic selection ( a ) and on day 5 ( c ). The horizontal and vertical lines in the representative dot plots mark fluorescence intensity greater than that observed with isotype-matched controls for the anti-CD45, anti-CD34, and anti-COL1 antibodies. The morphology of the cells in culture was monitored under an inverted microscope and the microphotographs in panel b show representative images in phase-contrast mode taken at the indicated points in time. The expression of the type I interleukin (IL)-4 receptor subunits (IL-4R / common -chain ( c)), type II IL-4 receptor subunits (IL-4R / IL-13R 1), IL-13R 2, and IL-17RA on the membrane of control and asthmatic fibrocytes were evaluated by flow cytometry on day 5 ( d ). The relative level of expression was quantified by subtracting the median fluorescence intensity (MFI) of cells stained with each specific antibody from the MFI of cells stained with the corresponding isotype control and dividing the obtained value by the MFI of unstained cells. Data are expressed as the means and s.d. * P < 0.05 vs. control fibrocytes; * * P < 0.01 vs. control fibrocytes by the unpaired Student ’ s t -test; n = 5.

    Journal: Mucosal immunology

    Article Title: Interleukin (IL)-4, IL-13, and IL-17A differentially affect the profibrotic and proinflammatory functions of fibrocytes from asthmatic patients.

    doi: 10.1038/mi.2011.60

    Figure Lengend Snippet: Figure 2 Isolation and phenotypic analysis of circulating fibrocytes. CD34 + cells were isolated from the peripheral blood by positive immunomagnetic selection and cultured for 5 days to obtain a pure population of mature fibrocytes. The non-adherent cells were removed after the first 48 h and the adherent cells were reincubated for the next 3 days in fresh medium. Flow cytometric analysis of the isolated cells was performed soon after the immunomagnetic selection ( a ) and on day 5 ( c ). The horizontal and vertical lines in the representative dot plots mark fluorescence intensity greater than that observed with isotype-matched controls for the anti-CD45, anti-CD34, and anti-COL1 antibodies. The morphology of the cells in culture was monitored under an inverted microscope and the microphotographs in panel b show representative images in phase-contrast mode taken at the indicated points in time. The expression of the type I interleukin (IL)-4 receptor subunits (IL-4R / common -chain ( c)), type II IL-4 receptor subunits (IL-4R / IL-13R 1), IL-13R 2, and IL-17RA on the membrane of control and asthmatic fibrocytes were evaluated by flow cytometry on day 5 ( d ). The relative level of expression was quantified by subtracting the median fluorescence intensity (MFI) of cells stained with each specific antibody from the MFI of cells stained with the corresponding isotype control and dividing the obtained value by the MFI of unstained cells. Data are expressed as the means and s.d. * P < 0.05 vs. control fibrocytes; * * P < 0.01 vs. control fibrocytes by the unpaired Student ’ s t -test; n = 5.

    Article Snippet: For intracellular staining of COL1, cells were permeabilized with 0.3 % saponin solution (Sigma-Aldrich, St Louis, MO) in Tris-buffered saline and sequentially 148 VOLUME 5 NUMBER 2 | MARCH 2012 | www.nature.com/mi incubated with a rabbit anti-human COL1 ( 2 chain) (Novus Biologicals, Littletone, CO), a biotinylated goat anti-rabbit secondary antibody (Novus Biologicals), and rhodamine red X-conjugated streptavidin (Jackson ImmunoResearch, Bar Harbor, ME).

    Techniques: Isolation, Selection, Cell Culture, Fluorescence, Inverted Microscopy, Expressing, Membrane, Control, Flow Cytometry, Staining